Moving Toward a Cure for More Patients With Hodgkin Lymphoma: Expert Guidance and Case Discussions

In this online educational program, which will include a CME-certified on-demand Webcast, downloadable slides, and ClinicalThought commentaries, expert faculty explore evolving care for patients with Hodgkin lymphoma, including frontline treatment, second-line options, and investigational strategies.

To register for a live symposium on Hodgkin lymphoma at the San Diego Hematology meeting in November, please click here.

Robert W. Chen, MD


Recent studies have shifted the paradigm of how newly diagnosed advanced Hodgkin lymphoma is optimally treated for many patients. Here’s my take.

Robert W. Chen, MD Released: September 13, 2018
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

This activity is supported by educational grants from
Seattle Genetics
Takeda Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?